CClinicalTrials.gg
RecruitingNCT05485675SMWIIUpdated Jan 14, 2026

Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program

An interventional study of Stand & Move at Work and Stand & Move at Work+ in Sedentary Behavior, sponsored by Arizona State University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-14.

Sponsored by Arizona State University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Feb 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Oct 2022; still recruiting 4 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
4,800
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a 2-arm group-randomized hybrid effectiveness-implementation (HEI type 2) study to test an evidence-based intervention (EBI) known as Stand \& Move at Work(SMW) to reduce sedentary time in the workplace, and to test the role of expert facilitation (SMW+) for improving intervention fidelity.

Read the detailed description

Primary Aim: To assess worksite-level reduction in sedentary time and intervention fidelity over 12 months Secondary Aim: To assess cost effectiveness of the intervention at 12 and 24 months

02

Conditions studied

  • Sedentary Behavior

Browse trials for

Keywords

  • worksite health
  • sit-stand workstations
  • multilevel intervention
  • implementation science
  • fidelity
  • facilitation
  • effectiveness
  • sedentary behavior
  • posture
  • Light physical activity
03

In context

Sedentary Behavior

332 studies on the registry are indexed under Sedentary Behavior; 155 are open to participants now.

This study's planned enrollment of 4,800 is above the median of 70 across 287 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

Arizona State University is the lead sponsor of 234 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Worksite-Level Inclusion Criteria:

  • More than 80% of employees work full time (30+ hours per week).
  • At least 45 employees in the worksite with sit-stand workstations working at least three days per week
  • Occupations require primarily desk-based work (e.g., computer- and telephone-based)
  • Willing to allow the researchers to distribute online research surveys to all employees in order to allow the program to be evaluated.
  • Allow 30 randomly selected individuals to wear an activity monitor in several 7-day intervals across two years.
  • Willing to be randomized to either intervention.
  • Willing to identify one or more worksite champions to implement the Stand \& Move at Work™ program.

Worksite-level exclusion criteria:

  • Involved in previous interventions to reduce sitting and increase standing and moving at work in the last 24 months.
  • Involved in the Stand and Move I intervention.
  • Another worksite within the same organization is participating in the program and contamination across those worksites cannot be avoided.

Employee-level inclusion criteria:

  • 18 years or older
  • Willing to provide informed consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
4,800 participants (estimated)

Study arms

  • Active comparator
    Stand & Move at Work

    Given an evidence-based workplace program to reduce sedentary behavior and increase standing and moving using a web-based platform. The web platform has a toolkit with strategies and guides for the worksite Champions to address changes at the environmental, social, and cultural levels.

    Behavioral: Stand & Move at Work

  • Experimental
    Stand & Move at Work+

    This arm will receive access to the same web-based platform and toolkit as the other arm. Additionally, worksites in this arm will be assigned and expert facilitator who will meet regularly with the worksite Champions to assist with implementation.

    Behavioral: Stand & Move at Work+

Interventions

  • BehavioralStand & Move at Work

    Web-based platform only.

    Also known as: SMW

  • BehavioralStand & Move at Work+

    Web-based platform and support from an expert facilitator

    Also known as: SMW+

06

What researchers measure

Primary outcomes

  1. Changes in posture

    Accelerometer-based (activPAL) sensor fixed to the thigh that measures sitting, standing, and lying down over 7 days.

    Time frame: Baseline, 3 month, 12 months, and 24 months

  2. Competence/Adherence

    A questionnaire-based assessment of intervention fidelity completed by study champions (competence and adherence) through an online portal. Based on Likert-scales and interval scales. SCORING RANGE

    Time frame: 3 months

  3. Competence/Adherence

    A questionnaire-based assessment of intervention fidelity completed by study champions (competence and adherence) through an online portal. Based on Likert-scales and interval scales. SCORING RANGE

    Time frame: 12 months

  4. Competence/Adherence

    A questionnaire-based assessment of intervention fidelity completed by study champions (competence and adherence) through an online portal. Based on Likert-scales and interval scales. SCORING RANGE

    Time frame: 24 months

  5. Intervention Fidelity

    A questionnaire-based assessment of intervention fidelity completed by study participants regarding the advocates (competence and adherence) through an online portal. SCORING RANGE

    Time frame: 3 months

  6. Intervention Fidelity

    A questionnaire-based assessment of intervention fidelity completed by study participants regarding the advocates (competence and adherence) through an online portal. SCORING RANGE

    Time frame: 12 months

  7. Intervention Fidelity

    A questionnaire-based assessment of intervention fidelity completed by study participants regarding the advocates (competence and adherence) through an online portal. SCORING RANGE

    Time frame: 24 months

  8. Researcher derived measures of fidelity

    A single composite measure of directly-observed intervention delivery assessed via web analytics, participation rates, and other calculated measures of fidelity.

    Time frame: 3 months

  9. Researcher derived measures of fidelity

    A single composite measure of directly-observed intervention delivery assessed via web analytics, participation rates, and other calculated measures of fidelity.

    Time frame: 12 months

  10. Researcher derived measures of fidelity

    A single composite measure of directly-observed intervention delivery assessed via web analytics, participation rates, and other calculated measures of fidelity.

    Time frame: 24 months

Secondary outcomes

  1. Comparison of program-related costs

    Program-related costs above and beyond cost of sit-stand workstation which may include advocate time spent implementing the intervention and intervention supplies.

    Time frame: Baseline, 3 month, 12 months, and 24 months.

  2. Change in health-related quality of life

    36-Item Short Form Survey (SF36) assesses quality of life that will be used to estimate incremental cost effectiveness. Scored from 0 to 100, with 0 being maximum disability and 100 being no disability.

    Time frame: Baseline, 3 month, 12 months, and 24 months.

  3. Change in musculoskeletal pain

    The Nordic Musculoskeletal Questionnaire (NMQ) assesses pain by bodily region on a Likert-type scale SCORING RANGE.

    Time frame: Baseline, 3 months, 12 months, and 24 months.

  4. Change in Work Productivity and Activity Impairment Questionnaire - General Health

    Work Productivity and Activity Impairment Questionnaire: General Health (WPAI:GH) assesses impairment in paid work and activities in the preceding 7 days on an interval and Likert-type scale with a higher score indicating greater impariment.

    Time frame: Baseline, 3 months, 12 months, and 24 months.

Other outcomes

  1. Change in sedentary behavior

    Sedentary behavior questionnaire (SBQ) is a brief questionnaire to assess time spent sitting in different work and non-work contexts SCORING RANGE

    Time frame: Baseline, 3 month, 12 months, and 24 months.

07

Study locations

1 of 1 sites recruiting
  • Arizona State University College of Health Solutions
    Phoenix, Arizona 85004, United States
    • Matthew Buman, PhD · Contact · mbuman@asu.edu · 602-496-8617
    • Arlene Fernandez · Contact · arlene11@asu.edu · 6025433756
    • Matthew Buman, PhD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Access to databases and associated software tools generated under the project will be available for educational, research and non-profit purposes. Such access will be provided using web-based applications, as appropriate. Publication of data shall occur during the project, if appropriate, and at the end of the project, consistent with normal scientific practices. Research data to document, support and validate research findings will be made available after the main findings from the final research data set have been accepted for publication. Such research data will be de-identified to prevent the disclosure of personal identifiers.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05485675
Lead sponsor
Arizona State University
Collaborators
National Cancer Institute (NCI), University of Minnesota, The University of Queensland, University of Nebraska, University of Utah, University of Virginia
Responsible party
Matthew P Buman, PhD (Professor, Arizona State University) — Principal investigator
First posted
Aug 3, 2022
Start date
Oct 7, 2022
Primary completion
Feb 28, 2026 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Jan 14, 2026

Study contacts

Matthew Buman, PhD
Contact
mbuman@asu.edu
602-496-8617
Arlene Fernandez
Contact
arlene11@asu.edu
6025433756
Matthew Buman, PhD
principal investigator · Arizona State University College of Health Solutions
Mark Pereira, PhD
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion